UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049198
Receipt number R000051614
Scientific Title Prevalence of preoperative cognitive impairment and related factors.
Date of disclosure of the study information 2022/10/12
Last modified on 2022/10/12 12:16:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence of cognitive impairment before surgery and factors associated with cognitive impairment.

Acronym

Investigation of preoperative cognitive impairment

Scientific Title

Prevalence of preoperative cognitive impairment and related factors.

Scientific Title:Acronym

Prevalence of preoperative cognitive impairment and related factors.

Region

Japan


Condition

Condition

Patients 65 years and older scheduled for non-cardiac surgery under general anesthesia.
Patients undergoing preoperative evaluation at the Perioperative Management Center

Classification by specialty

Surgery in general Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Preoperative cognitive decline is a risk factor for postoperative delirium and has been linked to longer hospital stays and increased mortality, and the American Geriatrics Society and the American Society of Anesthesiologists recommend preoperative cognitive screening in all patients over 65 years of age undergoing surgery (J Am Geriatr Soc 2018;66:19- 21 ASA Monitor 4 2018; 82:36-38). Although several studies have investigated the relationship between preoperative cognitive function and postoperative delirium, few reports have focused on the prevalence of preoperative cognitive decline, with a prevalence of 57.2% in patients undergoing noncardiac surgery in South Africa (Br J Anaesth 2020;125:275-81) and 16.1% in ambulatory surgery patients in the United States % (Anesth Analg 2019;129:e5-e7), respectively. These results indicate that the prevalence of preoperative cognitive decline is influenced by the environment. However, there are no reports on hospitalized patients in developed countries. Therefore, we will conduct a study to investigate the prevalence of preoperative cognitive decline in patients undergoing scheduled surgery at our hospital and to examine the factors associated with it.

Basic objectives2

Others

Basic objectives -Others

Studies to determine prevalence

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

To determine the prevalence of preoperative cognitive impairment.

Key secondary outcomes

To evaluate the correlation between cognitive function and grip strength, nutritional status, and oral frailty. To evaluate the factors associated with cognitive function. To evaluate the effect of perioperative factors on postoperative delirium and postoperative complications.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for non-cardiac surgery under general anesthesia.
Patients undergoing preoperative evaluation at the Perioperative Management Center.

Key exclusion criteria

Patients who were refused to participate in the study.
Patients who have been diagnosed with dementia.
Patients with limited use of their dominant hand.
Patients who are unable to perform preoperative assessment due to visual or hearing impairment.
Patients with inadequate preoperative assessment items will be excluded from the analysis.

Target sample size

274


Research contact person

Name of lead principal investigator

1st name Shohei
Middle name
Last name Nakatani

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara

TEL

0744-22-3051

Email

nsm520102@naramed-u.ac.jp


Public contact

Name of contact person

1st name Shohei
Middle name
Last name Nakatani

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara

TEL

0744-22-3051

Homepage URL


Email

nsm520102@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University

Address

840 Shijo-cho, Kashihara, Nara

Tel

0744223051

Email

nsm520102@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 07 Month 25 Day

Date of IRB

2021 Year 10 Month 01 Day

Anticipated trial start date

2021 Year 10 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

NA


Management information

Registered date

2022 Year 10 Month 12 Day

Last modified on

2022 Year 10 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051614


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name